Papers
9
Total Citations
87
H-Index
5
About
Thomas Yung is a radiation oncologist whose research has made meaningful contributions to the management of localized prostate cancer, with a particular focus on stereotactic body radiation therapy (SBRT) and its associated toxicities. His work centers on optimizing patient outcomes by characterizing and mitigating the side effects of high-dose, hypofractionated radiotherapy, including urinary morbidity, dysuria, proctitis, and hormone-related symptoms following androgen deprivation therapy. Among his most impactful contributions, Yung's 2016 study on acute urinary morbidity following prostate SBRT — which garnered 24 citations — demonstrated the value of prophylactic alpha-adrenergic antagonists and urethral dose reduction in reducing treatment-related discomfort. His investigations into combining intensity-modulated radiation therapy with SBRT boost for unfavorable-risk prostate cancer have provided clinicians with a less invasive alternative to brachytherapy, with outcomes tracked across three- and five-year follow-up periods. He has also contributed to clinical trial methodology through his work on early rectal morbidity assessment. Collectively accumulating over 85 citations, Yung's research reflects a sustained commitment to improving quality of life for prostate cancer patients navigating complex, multi-modality treatment regimens.
Research Focus
Key Achievements
Top Papers
- 1
- 2
- 3
- 4
- 5
- 6
- 7
- 8
- 9